Trabajos de Cristina Saura

Clinical Medicine


  Listando 48 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   3   Wikipedia   94   News   1   Policy
Article Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer Modi, Shanu; Saura, Cristina; Yamashita, Toshinari; Park, Yeon Hee; Kim, Sung-Bae; Tamura, Kenji; Andre, Fabrice; Iwata, Hiroji; Ito, Yoshinori; Tsurutani, Junji; Sohn, Joohyuk; Denduluri, Neelima; Perrin, Christophe; Aogi, Kenjiro; Tokunaga, Eriko; Im, Se NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2020) DOI / 10.1056/nejmoa1914510 Bronze, Green accepted
Mentions   0   Wikipedia   37   News   0   Policy
Article Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer Chic, Nuria; Luen, Stephen J.; Nuciforo, Paolo; Salgado, Roberto; Fumagalli, Debora; Hilbers, Florentine; Wang, Yingbo; de Azambuja, Evandro; Lang, Istvan; Di Cosimo, Serena; Saura, Cristina; Huober, Jens; Prat, Aleix; Loi, Sherene JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021) DOI / 10.1093/jnci/djab057
Mentions   0   Wikipedia   29   News   0   Policy
Article HER kinase inhibition in patients with HER2-and HER3-mutant cancers Hyman, David M.; Piha-Paul, Sarina A.; Won, Helen; Rodon, Jordi; Saura, Cristina; Shapiro, Geoffrey I.; Juric, Dejan; Quinn, David I.; Moreno, Victor; Doger, Bernard; Mayer, Ingrid A.; Boni, Valentina; Calvo, Emiliano; Loi, Sherene; Lockhart, Albert C.; Er NATURE 0028-0836 (2018) DOI / 10.1038/nature25475 Green accepted
Mentions   0   Wikipedia   22   News   0   Policy
Article Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study Banerji, Udai; van Herpen, Carla M. L.; Saura, Cristina; Thistiethwaite, Fiona; Lord, Simon; Moreno, Victor; Macpherson, Iain R.; Boni, Valentina; Rolfo, Christian; de Vries, Elisabeth G. E.; Rottey, Sylvie; Geenen, Jilt; Eskens, Ferry; Gil-Martin, Marta; LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30328-6 Green accepted
Mentions   0   Wikipedia   32   News   0   Policy
Article Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >= 2 HER2-Directed Regimens: Phase III NALA Trial Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun; Dai, Ming-Shen; Chen, Shang-Wen; Hurvitz, Sara A.; Kim, Sung-Bae; Moy, Beverly; Delaloge, Suzette; Gradishar, William; Masuda, Norikazu; Palacova, Marketa; Trudeau, Maureen E.; Mattson, Johanna; Yap, Yoon JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.20.00147 Gold other, Green published
Mentions   0   Wikipedia   4   News   0   Policy
Review Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis Lambertini, Matteo; Blondeaux, Eva; Bruzzone, Marco; Perachino, Marta; Anderson, Richard A.; de Azambuja, Evandro; Poorvu, Philip D.; Kim, Hee Jeong; Villarreal-Garza, Cynthia; Pistilli, Barbara; Vaz-Luis, Ines; Saura, Cristina; Ruddy, Kathryn J.; Franzoi, JOURNAL OF CLINICAL ONCOLOGY (2021) DOI / 10.1200/jco.21.00535
Mentions   0   Wikipedia   9   News   0   Policy
Article Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer, LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(19)30786-7
Mentions   0   Wikipedia   12   News   0   Policy
Article p95HER2-T cell bispecific antibody for breast cancer treatment Rius Ruiz, Irene; Vicario, Rocio; Morancho, Beatriz; Bernado Morales, Cristina; Arenas, Enrique J.; Herter, Sylvia; Freimoser-Grundschober, Anne; Somandin, Jitka; Sam, Johannes; Ast, Oliver; Martinez Barriocanal, Agueda; Luque, Antonio; Escorihuela, Marta; SCIENCE TRANSLATIONAL MEDICINE 1946-6234 (2018) DOI / 10.1126/scitranslmed.aat1445 Bronze, Green accepted
Mentions   0   Wikipedia   14   News   1   Policy
Article Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Kim, Sung-Bae; Dent, Rebecca; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Isakoff, Steven J.; Oliveira, Mafalda; Saura, Cristina; Wongchenko, Matthew J.; Kapp, Amy V.; Chan, Wai Y.; Singel, Stina M.; Maslyar, Daniel J.; Baselga, Jose LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30450-3 Green accepted
Mentions   0   Wikipedia   14   News   0   Policy
Article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial Rugo, Hope S.; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D.; Wright, Gail S.; Saura, Cristina; Escriva-de-Romani, Santiago; De Laurentiis, Michelino; Levy, Christelle; Brown-Glaberman, Ursa; Ferre JAMA ONCOLOGY 2374-2437 (2021) DOI / 10.1001/jamaoncol.2020.7932 Gold other, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article TNeoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Saura, Cristina; Hlauschek, Dominik; Oliveira, Mafalda; Zardavas, Dimitrios; Jallitsch-Halper, Anita; de la Pena, Lorena; Nuciforo, Paolo; Ballestrero, Alberto; Dubsky, Peter; Lombard, Janine M.; Vuylsteke, Peter; Castaneda, Carlos A.; Colleoni, Marco; Bor LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30334-1
Mentions   0   Wikipedia   2   News   0   Policy
Review Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) Condorelli, R.; Mosele, F.; Verret, B.; Bachelot, T.; Bedard, P. L.; Cortes, J.; Hyman, D. M.; Juric, D.; Krop, I.; Bieche, I.; Saura, C.; Sotiriou, C.; Cardoso, F.; Loibl, S.; Andre, F.; Turner, N. C. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz036 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin EBIOMEDICINE 2352-3964 (2021) DOI / 10.1016/j.ebiom.2021.103451 Green published, Gold
Mentions   0   Wikipedia   1   News   0   Policy
Article RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer Cruz, C.; Castroviejo-Bermejo, M.; Gutierrez-Enriquez, S.; Llop-Guevara, A.; Ibrahim, Y. H.; Gris-Oliver, A.; Bonache, S.; Morancho, B.; Bruna, A.; Rueda, O. M.; Lai, Z.; Polanska, U. M.; Jones, G. N.; Kristel, P.; de Bustos, L.; Guzman, M.; Rodriguez, O.; ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy099 Green published, Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials Dienstmann, Rodrigo; Garralda, Elena; Aguilar, Susana; Sala, Gemma; Viaplana, Cristina; Ruiz-Pace, Fiorella; Gonzalez-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco; Fasani, Roberta; Jimenez, Jose; Mart JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00398 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.638482 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer Smyth, Lillian M.; Piha-Paul, Sarina A.; Won, Helen H.; Schram, Alison M.; Saura, Cristina; Loi, Sherene; Lu, Janice; Shapiro, Geoffrey I.; Juric, Dejan; Mayer, Ingrid A.; Arteaga, Carlos L.; de la Fuente, Macarena I.; Brufksy, Adam M.; Spanggaard, Iben; M CANCER DISCOVERY 2159-8274 (2020) DOI / 10.1158/2159-8290.cd-19-0966 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts Gris-Oliver, Albert; Palafox, Marta; Monserrat, Laia; Braso-Maristany, Fara; Odena, Andreu; Sanchez-Guixe, Monica; Ibrahim, Yasir H.; Villacampa, Guillermo; Grueso, Judit; Pars, Mireia; Guzman, Marta; Rodriguez, Olga; Bruna, Alejandra; Hirst, Caroline S.; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-3324 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials Matos, Ignacio; Villacampa, Guillermo; Hierro, Cinta; Martin-Liberal, Juan; Berche, Roger; Pedrola, Anna; Brana, Irene; Azaro, Analia; Vieito, Maria; Saavedra, Omar; Gardeazabal, Itziar; Hernando-Calvo, Alberto; Alonso, Guzman; Galvao, Vladimir; de Olza, M EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.05.040 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical consequences of BRCA2 hypomorphism Castells-Roca, Laia; Gutierrez-Enriquez, Sara; Bonache, Sandra; Bogliolo, Massimo; Carrasco, Estela; Aza-Carmona, Miriam; Montalban, Gemma; Munoz-Subirana, Nuria; Pujol, Roser; Cruz, Cristina; Llop-Guevara, Alba; Ramirez, Maria J.; Saura, Cristina; Lasa, A NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-021-00322-9 Gold, Green published
Mentions   0   Wikipedia   3   News   0   Policy
Article Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial Hurvitz, Sara A.; Saura, Cristina; Oliveira, Mafalda; Trudeau, Maureen E.; Moy, Beverly; Delaloge, Suzette; Gradishar, William; Kim, Sung-Bae; Haley, Barbara; Ryvo, Larisa; Dai, Ming-Shen; Milovanov, Vladimir; Alarcon, Jesus; Kalmadi, Sujith; Cronemberger, ONCOLOGIST 1083-7159 (2021) DOI / 10.1002/onco.13830 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer The MANTA Phase 2 Randomized Clinical Trial Schmid, Peter; Zaiss, Matthias; Harper-Wynne, Catherine; Ferreira, Marta; Dubey, Sidharth; Chan, Stephen; Makris, Andreas; Nemsadze, Gia; Brunt, Adrian M.; Kuemmel, Sherko; Ruiz, Isabel; Perello, Antonia; Kendall, Anne; Brown, Janet; Kristeleit, Hartmut; C JAMA ONCOLOGY 2374-2437 (2019) DOI / 10.1001/jamaoncol.2019.2526 Green published, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer Braso-Maristany, Fara; Sanso, Miriam; Chic, Nuria; Martinez, Debora; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Ghiglione, Lucio; Carcelero, Esther; Garcia-Corbacho, Javier; Sanchez, Marcelo; Soy, Dolors; Jares, Pedro; Peg, Vicente; Saura, Cristina; Munoz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.710596 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus Capecitabine in Patients with Previously Treated Metastatic Breast Cancer Saura, Cristina; Matito, Judit; Oliveira, Mafalda; Wildiers, Hans; Brufksy, Adam M.; Waters, Simon H.; Hurvitz, Sara A.; Moy, Beverly; Kim, Sung-Bae; Gradishar, William J.; Queiroz, Geraldo Silva; Cronemberger, Eduardo; Wallweber, Gerald J.; Bebchuk, Judit CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-1584 Hybrid, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial Di Cosimo, Serena; Porcu, Luca; Agbor-tarh, Dominique; Cinieri, Saverio; Franzoi, Maria Alice; De Santis, Maria Carmen; Saura, Cristina; Huober, Jens; Fumagalli, Debora; Izquierdo, Miguel; Piccart, Martine; Daidone, Maria Grazia; de Azambuja, Evandro BREAST CANCER RESEARCH 1465-542X (2020) DOI / 10.1186/s13058-020-01356-w Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial Venet, David; Rediti, Mattia; Maetens, Marion; Fumagalli, Debora; Brown, David N.; Majjaj, Samira; Salgado, Roberto; Pusztai, Lajos; Harbeck, Nadia; El-Abed, Sarra; Wang, Yingbo; Saura, Cristina; Gomez, Henry; Semiglazov, Vladimir Fedorovich; de Azambuja, CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-1317
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers Jhaveri, Komal; Chang, Matthew T.; Juric, Dejan; Saura, Cristina; Gambardella, Valentina; Melnyk, Anton; Patel, Manish R.; Ribrag, Vincent; Ma, Cynthia X.; Aljumaily, Raid; Bedard, Philippe L.; Sachdev, Jasgit C.; Dunn, Lara; Won, Helen; Bond, John; Jones, CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-20-2657
Mentions   0   Wikipedia   0   News   0   Policy
Article Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib Ulaner, Gary A.; Saura, Cristina; Piha-Paul, Sarina A.; Mayer, Ingrid; Quinn, David; Jhaveri, Komal; Stone, Ben; Shahin, Seta; Mann, Grace; Dujka, Melanie; Bryce, Richard; Meric-Bernstam, Funda; Solit, David B.; Hyman, David M. CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-19-1658 Green accepted
Mentions   0   Wikipedia   2   News   0   Policy
Article The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1 Nadal-Serrano, Mercedes; Morancho, Beatriz; Escriva-de-Romani, Santiago; Morales, Cristina Bernado; Luque, Antonio; Escorihuela, Marta; Bravo, Martin Espinosa; Peg, Vicente; Dijcks, Fred A.; Dokter, Wim H. A.; Cortes, Javier; Saura, Cristina; Arribas, Joaq CANCERS (2020) DOI / 10.3390/cancers12030670 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer Dent, Rebecca; Oliveira, Mafalda; Isakoff, Steven J.; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Saura, Cristina; Wongchenko, Matthew J.; Xu, NA; Bradley, Denise; Reilly, Sarah-Jayne; Mani, Aruna; Kim, Sung-Bae BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2021) DOI / 10.1007/s10549-021-06143-5
Mentions   0   Wikipedia   0   News   0   Policy
Article Neratinib plus capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and >= 2 prior HER2-directed regimens Moy, Beverly; Oliveira, Mafalda; Saura, Cristina; Gradishar, William; Kim, Sung-Bae; Brufsky, Adam; Hurvitz, Sara A.; Ryvo, Larisa; Fagnani, Daniele; Kalmadi, Sujith; Silverman, Paula; Delaloge, Suzette; Alarcon, Jesus; Kwong, Ava; Lee, Keun Seok; Ang, Pet BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2021) DOI / 10.1007/s10549-021-06217-4 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy Saura, Cristina; Sanchez, Olga; Martinez, Sandra; Dominguez, Carmen; Dienstmann, Rodrigo; Ruiz-Pace, Fiorella; Cespedes, Maria Concepcio; Penuelas, Angeles; Cortes, Javier; Llurba, Elisa; Cordoba, Octavi CANCERS (2021) DOI / 10.3390/cancers13040923 Gold DOAJ
Mentions   0   Wikipedia   0   News   0   Policy
Article A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation Castroviejo-Bermejo, Marta; Cruz, Cristina; Llop-Guevara, Alba; Gutierrez-Enriquez, Sara; Ducy, Mandy; Hussein Ibrahim, Yasir; Gris-Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzman, Marta; Rodriguez, Olga; Grueso, Judit; Bonache, Sandra; Mol EMBO MOLECULAR MEDICINE 1757-4676 (2018) DOI / 10.15252/emmm.201809172 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer Garrido-Castro, Ana C.; Saura, Cristina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begona; Gavila, Joaquin; Serra, Violeta; Prat, Aleix; Pare, Laia; Celiz, Pamela; Villagrasa, Patricia; Li, Yisheng; Savoie, Jennifer; Xu, Zhan; Arteaga, Car BREAST CANCER RESEARCH 1465-542X (2020) DOI / 10.1186/s13058-020-01354-y Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Breast cancer during pregnancy: matched study of diagnostic approach, tumor characteristics, and prognostic factors Reyes, Eduardo; Xercavins, Natalia; Saura, Cristina; Espinosa, Martin; Gil, Antonio; Cordoba, Octavi TUMORI J 0300-8916 (2020) DOI / 10.1177/0300891620925158
Mentions   0   Wikipedia   0   News   0   Policy
Article Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer Serna, Garazi; Simonetti, Sara; Fasani, Roberta; Pagliuca, Francesca; Guardia, Xavier; Gallego, Paqui; Jimenez, Jose; Peg, Vicente; Saura, Cristina; Eppenberger-Castori, Serenella; Ramon y Cajal, Santiago; Terracciano, Luigi; Nuciforo, Paolo BREAST 0960-9776 (2020) DOI / 10.1016/j.breast.2020.07.002 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I; Andersen, J.; Passos-Coelho, J. L.; Gil Gil, M.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; de la Pena, L.; Xu, N.; Wongchenko, M.; Shi, Z.; Singel, S. M.; Isakoff, S. J. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz177 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients Baird, Richard D.; van Rossum, Annelot G. J.; Oliveira, Mafalda; Beelen, Karin; Gao, Meiling; Schrier, Mariette; Mandjes, Ingrid A. M.; Garcia-Corbacho, Javier; Vallier, Anne-Laure; Dougall, Greig; van Werkhoven, Erik; Linossi, Constanza; Kumar, Sanjeev; v CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-19-0508 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement Colomer, Ramon; Saura, Cristina; Sanchez-Rovira, Pedro; Pascual, Tomas; Rubio, Isabel T.; Burgues, Octavio; Marcos, Lourdes; Rodriguez, Cesar A.; Martin, Miguel; Lluch, Ana ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2018-0228 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors Saura, Cristina; Roda, Desamparados; Rosello, Susana; Oliveira, Mafalda; Macarulla, Teresa; Alejandro Perez-Fidalgo, Jose; Morales-Barrera, Rafael; Manuel Sanchis-Garcia, Juan; Musib, Luna; Budha, Nageshwar; Zhu, Jin; Nannini, Michelle; Chan, Wai Y.; Bohor CANCER DISCOVERY 2159-8274 (2017) DOI / 10.1158/2159-8290.cd-16-0512 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer Dickler, Maura N.; Saura, Cristina; Richards, Donald A.; Krop, Ian E.; Cervantes, Andres; Bedard, Philippe L.; Patel, Manish R.; Pusztai, Lajos; Oliveira, Mafalda; Cardenas, Alison K.; Cui, Na; Wilson, Timothy R.; Stout, Thomas J.; Wei, Michael C.; Hsu, Je CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-18-0613 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer Oliveira, Mafalda; Garrigos, Laia; Assaf, Juan David; Escriva-de-Romani, Santiago; Saura, Cristina EXPERT REVIEW OF ANTICANCER THERAPY 1473-7140 (2020) DOI / 10.1080/14737140.2020.1807947
Mentions   0   Wikipedia   0   News   0   Policy
Article Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study Gil-Gil, Miguel J.; Bellet, Meritxell; Bergamino, Milana; Morales, Serafin; Barnadas, Agusti; Manso, Luis; Saura, Cristina; Fernandez-Ortega, Adela; Garcia-Martinez, Elena; Martinez-Janez, Noelia; Mele, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Ma FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.645026 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study) Gonzalez-Santiago, Santiago; Saura, Cristina; Ciruelos, Eva; Luis Alonso, Jose; de la Morena, Pilar; Santisteban Eslava, Marta; Gallegos Sancho, Maria Isabel; de Luna, Alicia; Dalmau, Elsa; Servitja, Sonia; Ruiz Borrego, Manuel; Ignacio Chacon, Jose BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2020) DOI / 10.1007/s10549-020-05866-1
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating Tumor DNA and Biomarker Analyses From the LOTUS Randomized Trial of First-Line Ipatasertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer Wongchenko, Matthew J.; Kim, Sung-Bae; Saura, Cristina; Oliveira, Mafalda; Lipson, Doron; Kennedy, Mark; Greene, Mandy; Breese, Virginia; Mani, Aruna; Xu, NA; Dent, Rebecca JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00396
Mentions   0   Wikipedia   0   News   0   Policy
Article HER2-positive breast cancer: Current and new therapeutic strategies Escriva-de-Romani, Santiago; Arumi, Miriam; Bellet, Meritxell; Saura, Cristina BREAST 0960-9776 (2018) DOI / 10.1016/j.breast.2018.03.006
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer Abramson, Vandana G.; Oliveira, Mafalda; Cervantes, Andres; Wildiers, Hans; Patel, Manish R.; Bauer, Todd M.; Bedard, Philippe L.; Becerra, Carlos; Richey, Stephen; Wei, Michael C.; Reyner, Eric; Bond, John; Cui, Na; Wilson, Timothy R.; Moore, Heather M.; BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-019-05360-3
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy Pistilli, B.; Pluard, T.; Urruticoechea, A.; Farci, D.; Kong, A.; Bachelot, T.; Chan, S.; Han, H. S.; Jerusalem, G.; Urban, P.; Robinson, D.; Mouhaer, S. L.; Tomaso, E. D.; Massacesi, C.; Saura, C. BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2018) DOI / 10.1007/s10549-017-4596-7

Más rankings

InfluScience

Contacto
Cerrar